Corrigendum to <'Novel therapeutic strategies for multiple myeloma'> <[Experimental Hematology 2015; 43: 732-741]>

Affiliations

¹ Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Chiba, Japan. Electronic address: naoyamimura@chiba-u.jp.
² Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
³ Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: kenneth_anderson@dfci.harvard.edu.

Free article

Published Erratum

Naoya Mimura et al. Exp Hematol. 2021 Nov.

Free article

. 2021 Nov:103:75.

doi: 10.1016/j.exphem.2021.08.007. Epub 2021 Aug 29.

¹ Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Chiba, Japan. Electronic address: naoyamimura@chiba-u.jp.
² Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
³ Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: kenneth_anderson@dfci.harvard.edu.

No abstract available

Erratum for

Novel therapeutic strategies for multiple myeloma.
Mimura N, Hideshima T, Anderson KC. Mimura N, et al. Exp Hematol. 2015 Aug;43(8):732-41. doi: 10.1016/j.exphem.2015.04.010. Epub 2015 Jun 26. Exp Hematol. 2015. PMID: 26118499 Free PMC article. Review.